Literature DB >> 31584530

NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation-Potential Influence on the Myocardium.

Marina Sokolova1,2, Trine Ranheim1,3, Mieke C Louwe1,2, Bente Halvorsen1,3, Arne Yndestad1, Pål Aukrust1,2,4.   

Abstract

Metabolic and immune systems are among the most fundamental requirements for survival. Many metabolic and immune response pathways or nutrient- and pathogen-sensing systems are evolutionarily conserved throughout species. As a result, the immune response and metabolic regulation are highly integrated and the proper function of each is dependent on the other. This interaction between metabolic disturbances and the immune system has been most extensively studied in disorders related to obesity such as insulin resistance, type 2 diabetes, and nonalcoholic fatty liver disease. Metabolically induced inflammation seems also to play a role in the development and progression of atherosclerosis including its complications such as myocardial infarction (MI) and post-MI remodeling. There are several lines of evidence suggesting that NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome is a sensor of metabolic stress linking metabolic disturbances to inflammation. Here, we will discuss the role of the NLRP3 inflammasome in the pathogenesis of obesity and diabetes, 2 important risk factors for atherosclerosis and MI. We will also discuss the role of NLRP3 inflammasome in the interaction between metabolic disturbances and myocardial inflammation during MI and during metabolically induced myocardial remodeling.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31584530     DOI: 10.1097/FJC.0000000000000704

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  12 in total

1.  NLRP3 inflammasome as a novel therapeutic target for heart failure.

Authors:  Shuangcui Wang; Jiaqi Zhang; Yuli Wang; Xijuan Jiang; Maojuan Guo; Zhen Yang
Journal:  Anatol J Cardiol       Date:  2022-01       Impact factor: 1.596

Review 2.  Emerging Roles of Inflammasomes in Cardiovascular Diseases.

Authors:  Yingnan Liao; Kui Liu; Liyuan Zhu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

3.  Phenotype and Response to PAMPs of Human Monocyte-Derived Foam Cells Obtained by Long-Term Culture in the Presence of oxLDLs.

Authors:  Anna Nogieć; Małgorzata Bzowska; Agnieszka Demczuk; Chen Varol; Krzysztof Guzik
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

Review 4.  The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions.

Authors:  Rameez Hassan Pirzada; Nasir Javaid; Sangdun Choi
Journal:  Genes (Basel)       Date:  2020-01-27       Impact factor: 4.096

Review 5.  The Role of the Effects of Endoplasmic Reticulum Stress on NLRP3 Inflammasome in Diabetes.

Authors:  Shuangyu Lv; Xiaotian Li; Honggang Wang
Journal:  Front Cell Dev Biol       Date:  2021-04-14

6.  NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet.

Authors:  Marina Sokolova; Kuan Yang; Simen H Hansen; Mieke C Louwe; Martin Kummen; Johannes E R Hov; Ivar Sjaastad; Rolf K Berge; Bente Halvorsen; Pål Aukrust; Arne Yndestad; Trine Ranheim
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

Review 7.  Targeting NLRP3 Inflammasome in the Treatment Of Diabetes and Diabetic Complications: Role of Natural Compounds from Herbal Medicine.

Authors:  Ying Bai; Qianqian Mu; Xueli Bao; Jiacheng Zuo; Xin Fang; Jing Hua; Dongwei Zhang; Guangjian Jiang; Ping Li; Sihua Gao; Dandan Zhao
Journal:  Aging Dis       Date:  2021-10-01       Impact factor: 9.968

8.  Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation.

Authors:  Shuang Lin; Shanshan Dai; Jiahui Lin; Xiaohe Liang; Weiqi Wang; Weijian Huang; Bozhi Ye; Xia Hong
Journal:  Cardiovasc Ther       Date:  2022-03-14       Impact factor: 3.023

Review 9.  The Role of Endoplasmic Reticulum Stress and NLRP3 Inflammasome in Liver Disorders.

Authors:  Xueqin Lu; Haitao Huang; Xiaodi Fu; Chaoran Chen; Huiyang Liu; Honggang Wang; Dongdong Wu
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

10.  NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice.

Authors:  Lu Chen; Wenxiang Qing; Zexiong Yi; Guoxin Lin; Qianyi Peng; Fan Zhou
Journal:  Front Nutr       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.